← Back to insights

Transforming Dialysis Access in Indonesia: The Zero-CAPEX Model

Why revenue-sharing partnerships are the future of healthcare investment.

When evaluating resilient investment sectors and life-saving healthcare infrastructure, hemodialysis care stands in a category of its own.

For millions of patients suffering from End-Stage Renal Disease (ESRD) or severe Chronic Kidney Disease (CKD), hemodialysis is not an elective procedure, it is a non-negotiable, life-sustaining medical treatment. Patients typically require 4-hour sessions two to three times every single week to survive. Because kidney failure requires continuous management, patient demand remains stable across all economic cycles.

Despite this predictable demand, healthcare providers across Indonesia face a persistent bottleneck: the heavy capital expenditure required to establish and maintain modern dialysis units.

At Jawara Capital, through our portfolio company Binathera, we are dismantling this barrier. By combining strategic capital deployment with Binathera's Revenue / Profit-Sharing Model, we empower hospitals, clinics, and healthcare developers to expand essential kidney care with zero upfront equipment cost, creating a sustainable model for both clinical growth and resilient investment.

The Barrier: High CAPEX and Operational Complexity

Establishing a fully compliant, high-performing hemodialysis unit requires significant financial commitment:

• High-grade medical equipment: Hemodialysis machines and specialized treatment suites.
• Complex infrastructure: Industrial-grade Reverse Osmosis (RO) water purification systems critical for patient safety.
• Continuous supply chain: Reliable access to specialized consumables (dialyzers, blood lines, concentrate solutions).
• Compliance & maintenance: Ongoing biomedical servicing, staff training, and regulatory reporting.

For many regional hospitals, medical centers, and private practice groups, locking up capital in heavy assets creates unnecessary financial risk. As a result, facility expansion stalls, leaving local communities underserved and forcing patients to travel long distances for routine treatments.

The Solution: Binathera's Zero-CAPEX Profit-Sharing Model

Through Binathera, Jawara Capital eliminates traditional financial friction. Under our Revenue / Profit Sharing arrangement, healthcare facilities can deploy state-of-the-art dialysis infrastructure with zero upfront heavy CAPEX.

How the Model Works

• Binathera Provides: Sourcing, installation, and full equipment deployment (dialysis machines, water purification systems, and ongoing consumables supply).
• Your Facility Operates: Clinical management, nursing staff, and patient care.
• Shared Success: Earnings are shared based on actual patient usage, converting heavy fixed liabilities into an aligned operational partnership.

Key Strategic Advantages of Binathera

Binathera's approach goes beyond standard equipment distribution by providing full lifecycle partnership:

1. 1Zero Heavy CAPEX: Launch new units or expand existing machine count without burdening your balance sheet, preserving capital for core healthcare operations.
2. 2Vendor-Agnostic Sourcing: We source equipment from leading global and local OEMs with no brand lock-in, ensuring your facility gets the best technology tailored to your specific clinical needs.
3. 3Full Lifecycle Support: From professional installation and staff onboarding to ongoing technical maintenance, compliance reporting, and eventual hardware upgrades, you work with one trusted partner from start to finish.

Our 5-Step Partnership Roadmap

We guide every hemodialysis project from initial concept to long-term operation through a structured, 5-step process:

1. 1Discovery: We assess your clinical needs, patient volume, and long-term growth goals to understand your unique facility context.
2. 2Custom Strategy: We draft a tailored proposal and business model aligned directly with your financial and operational targets.
3. 3Deployment: Our engineering team handles professional equipment installation, RO water system integration, and team onboarding to ensure a seamless launch.
4. 4Ongoing Support: We provide continuous monitoring, preventive maintenance, technical assistance, and compliance reporting throughout the partnership.
5. 5Future Growth: We conduct joint evaluations and strategic planning for your next expansion or equipment upgrade cycle as patient demand grows.

Why Invest in Dialysis Infrastructure?

From an institutional and strategic investment perspective, hemodialysis infrastructure combines defensive financial metrics with high social impact:

• Inelastic Demand: Treatment cannot be delayed or substituted, ensuring high utilization and consistent cash flows.
• Predictable Operational Metrics: Recurring patient schedules enable accurate forecasting and financial stability.
• ESG & Social Impact: Expanding local dialysis capacity directly improves patient quality of life, reduces long travel burdens for families, and saves lives across Indonesian communities.

Let's Build Your Project Together

Bring your hemodialysis project to life with a partner that brings capital, technology, and end-to-end operational backing.

• Explore Jawara Capital: jawaracapital.com
• Direct Partnership Inquiries: Contact Binathera at admin@binathera.com
• Office Location: Wisma Nugra Santana, 3rd Floor, Jl. Jend. Sudirman Kav. 7–8, Jakarta Pusat 10220, Indonesia

← Back to insights

Building for Decades: Our Portfolio and How We Build It

At Jawara Capital, our role as a holding company goes beyond providing capital. We identify structural inefficiencies across Indonesia's most critical growth sectors and back capital-efficient, operationally backed business models that unlock long-term asset value.

Our strategy targets businesses built on non-discretionary demand, predictable cash flows, and massive operational moats. By combining our own capital with active execution, we help the companies we own convert heavy balance-sheet burdens (CAPEX) into recurring operational models (OPEX), manage financial and operational risk, streamline supply chains, and scale essential infrastructure across the archipelago.

Here is an inside look at our expanded portfolio verticals, their core operations, and why we chose to build them.

Healthcare infrastructure requires substantial upfront investment, yet access remains constrained across Indonesia. Our thesis in healthcare focuses on asset-light distribution models that expand clinical capacity alongside high-margin, specialized wellness services.

The explosion of digital lending, consumer finance, and SME banking across Indonesia has created an unprecedented volume of credit assets that require institutional-grade risk management and portfolio servicing.

As industrial and commercial operations expand in tropical Southeast Asia, energy consumption presents both a massive cost burden and an urgent decarbonization challenge, with cooling and process heat the largest line items.

Urban centers require space-efficient, high-yield residential models tailored to modern working professionals.

Indonesia's manufacturing growth requires reliable, heavy-duty industrial packaging to move raw materials, chemicals, and food-grade products across national and international supply chains.